NATCO Pharma launches generic blood cancer treatment medicine in U.S.
2026-03-04 - 12:43
The product is available in 1mg, 2mg, 3mg, and 4mg strengths and is distributed primarily through specialty pharmacies and clinics, NATCO Pharma said
Share this post: